Study guide

13.2 HBOT, Bioengineered Tissue, and Leech Therapy

WOCNCB Certified Wound Care Nurse CWCN

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CWCN Exam Facts 1.2 Eligibility: Traditional, Experiential, and WTA-C Credit 1.3 Fees, Retakes, Recertification, and Test Strategy

2 Skin Biology, History & Systemic Factors

2.1 Integumentary Anatomy and Skin Barrier 2.2 Healing Phases, Healing vs Non-Healing, and Biofilm 2.3 History, Psychosocial Factors, Nutrition, and Pain 2.4 Systemic Healing Factors and Medications

3 Diagnostics and the Focused Wound Exam

3.1 Vascular, Laboratory, Imaging, and Perfusion Studies 3.2 Wound Measurement, Periwound Signs, and Dermatologic Differentials 3.3 When and How to Culture a Wound

4 Pressure Injury Pathophysiology and Staging

4.1 Pressure Injury Pathophysiology and Risk Tools 4.2 NPIAP Stages 1 through 4 4.3 Unstageable, DTPI, MDRPI, and Mucosal Injuries

5 Lower-Extremity and Special Etiologies

5.1 Venous / LEVD Ulcer Assessment 5.2 Arterial / LEAD Ulcer Assessment and PAD Testing 5.3 Neuropathic Foot Ulcers, Charcot, and Wagner Grading 5.4 Mixed Disease, Atypical, Surgical, Traumatic, and Burn Wounds

6 Prevention and Support Surfaces

6.1 Risk-Based Prevention: Moisture, Nutrition, Mobility, Cognition 6.2 Repositioning, Shear Reduction, and Seating 6.3 Support Surface Types and Selection

7 Offloading, Moisture, and Skin Products

7.1 Offloading and Protective Footwear 7.2 MASD/IAD, MARSI Prevention, and Skin Care Products 7.3 Friction, Heel Protection, and Preventing Treatment Complications

8 Wound-Care Principles, Pain, and Studies

8.1 Moisture Balance, Dead Space, and Periwound Protection 8.2 Recommending Pain Management Modalities 8.3 Obtaining Cultures and Recommending Studies

9 Cleansing and Wound Bed Preparation

9.1 Wound Cleansing Regimens 9.2 TIME: Infection, Moisture, and Edge Optimization 9.3 Chemical Cauterization Indications

10 Debridement Modalities

10.1 Debridement Types, Indications, and Contraindications 10.2 Conservative Sharp vs Surgical/Excisional Debridement 10.3 Autolytic, Enzymatic, Biological, and Mechanical Debridement

11 Topical Therapies

11.1 Hydrating Dressings: Hydrogels, Films, Hydrocolloids 11.2 Absorbent Dressings: Foams, Alginates, Hydrofibers 11.3 Antimicrobials, Odor Control, and Periwound Integrity

12 Compression Therapy

12.1 Compression Types, Indications, and Contraindications 12.2 Static vs Dynamic Compression Application 12.3 Mixed Arterial-Venous Disease and Compression Safety

13 Advanced and Adjunctive Therapies

13.1 Negative Pressure Wound Therapy 13.2 HBOT, Bioengineered Tissue, and Leech Therapy 13.3 Hydrotherapy, Pulsed Lavage, Mist, Maggot Therapy, and Total Contact Casting

14 Patient-Centered Goals

14.1 Patient-Centered Care, Access, and Cultural Beliefs 14.2 Preventive, Palliative, Maintenance, and Curative Goals 14.3 Writing Patient-Focused Skin and Wound Goals

15 Evaluation, Modification, and Documentation

15.1 Evaluating Treatment Effectiveness 15.2 Interpreting Response and Modifying the Plan 15.3 Documentation, CMS Quality Context, and Surveillance

16 Patient and Caregiver Education

16.1 Health Literacy, Goals, and Teach-Back 16.2 Educating on Procedures, Skin Care, and Diagnostic Results 16.3 Modifiable Risk Factors and Resource Access

17 Educating Other Clinicians

17.1 Teaching Skin and Wound Principles, Procedures, and Goals 17.2 Infection Control, Repositioning, Moisture, Nutrition, and Trauma Avoidance for Teams 17.3 Recommending Non-Invasive and Invasive Next Steps

18 Collaboration, Referral, and Handoff

18.1 Support, Supply Access, Post-Acute Care, and Service Referrals 18.2 Referring for Studies and Specialty Consults 18.3 Handoff Communication Across Settings

13.2 HBOT, Bioengineered Tissue, and Leech Therapy

Key Takeaways Explain This Topic AI

Hyperbaric oxygen therapy delivers 100 percent oxygen at about 2.0–2.5 atmospheres absolute so dissolved oxygen, angiogenesis, and leukocyte killing can rise in a compromised bed.

A Wagner grade 3 or deeper diabetic foot ulcer after revascularization and infection control is a classic HBOT use; osteoradionecrosis, selected compromised flaps, and chronic refractory osteomyelitis are commonly cited UHMS-type indications.

Untreated pneumothorax is a hard stop for HBOT; some chemotherapies, claustrophobia, and middle-ear barotrauma risk are cautions.

Living bilayered constructs, acellular dermal matrices, allografts, and xenografts need a clean, well-perfused bed plus offloading or compression by etiology.

Medicinal leeches treat venous congestion of a flap: hirudin anticoagulates the bite, Aeromonas prophylaxis is typically required, and hemoglobin must be watched.

Last updated: September 2026

Hyperbaric oxygen as a systemic adjunct

Hyperbaric oxygen therapy (HBOT) places the person in a chamber that delivers 100 percent oxygen at about 2.0–2.5 atmospheres absolute (ATA) . Independent ExamFinch teaching for CWCN candidates treats HBOT as an advanced therapy in the same 030402 / 030406 cluster as NPWT and bioengineered tissue: you recognize when hypoxia is the remaining limiter and when the chamber is unsafe. Breathing room air at sea level dissolves little oxygen in plasma. Under pressure, plasma oxygen rises enough to diffuse farther into poorly perfused but not dead tissue, support collagen deposition and angiogenesis , and restore leukocyte oxidative burst so neutrophils can kill. Sessions often last about 90–120 minutes over a multi-week series; exact protocols belong to the hyperbaric team.

HBOT does not bypass a blocked tibial artery. If the foot is critically ischemic, the first call is vascular reconstruction or endovascular inflow, not a standing order for thirty dives. Transcutaneous oxygen measurements are sometimes used to show that a hypoxic wound can respond when oxygen is raised; a flat, nonresponsive tracing is a reason to fix perfusion first.

Commonly cited indications—not a WOCNCB list

Wound-related uses that appear in Undersea and Hyperbaric Medical Society (UHMS)–type indication lists, and that CWCN-style items often sample, include:

Diabetic foot ulcer Wagner grade 3 or deeper (deep abscess, osteomyelitis, or more extensive necrosis) after glucose, offloading, debridement, and revascularization have been optimized

Osteoradionecrosis and selected delayed radiation soft-tissue injury, because irradiated beds are hypovascular and hypocellular

  • Selected compromised flaps or grafts that are hypoxic but still viable
  • Chronic refractory osteomyelitis that has already had surgery and culture-guided antibiotics

Independent ExamFinch teaching presents those as commonly cited UHMS-type indications . They are not published here as an official WOCNCB indication list, and they are not a claim that every stalled wound deserves a chamber. Wagner 1 or 2 ulcers that have never been offloaded are a dressing-and-shoe problem. A wet gangrenous foot that still needs source control is an operating-room problem.

Candidate pattern Why HBOT is discussed What must already be true

Wagner 3+ DFU Deep infection or bone in a diabetic host after the obvious work Perfusion optimized, infection drained, offloading in place

Osteoradionecrosis Radiation left a hypovascular mandible or pelvis Oncology and surgical plans are active

Compromised flap Tissue is dusky from hypoxia, not from a dead arterial pedicle A still-viable flap, not a black eschar

Refractory osteomyelitis Biofilm and hypoxic bone impair host defense Debridement and antibiotics already started

Contraindications and chamber cautions

Untreated pneumothorax is the classic absolute contraindication. Expanding trapped air in a pleural space under pressure can tension. Treat the chest first.

Cautions you should be able to name:

Some chemotherapies (bleomycin pulmonary toxicity, doxorubicin cardiotoxicity, and cisplatin in older hyperbaric teaching) need oncology clearance; the wound nurse flags the drug list rather than clearing the dive.

Claustrophobia can make a monoplace chamber intolerable; anxiolysis or a multiplace option is a logistics issue, not stubbornness.

Barotrauma to ears and sinuses: people who cannot equalize need tympanostomy consideration or a delay.

Severe obstructive lung disease with CO2 retention, uncontrolled seizure disorder, and some implanted devices are program-specific screens.

Fever, a new cough, or chest pain before a dive is a same-day hold. HBOT is not a walk-in substitute for a missing ABI.

Bioengineered and cellular tissue products

These products are advanced living or processed tissues , not a thicker foam. Classes CWCN candidates should separate:

Living bilayered constructs (cultured keratinocytes over a fibroblast-containing dermis) that can deliver living cells and matrix signals

  • Acellular dermal matrices that provide a collagen scaffold for host cells to populate
  • Allografts (human donor skin or dermis) used as a temporary biologic cover or scaffold
  • Xenografts (typically porcine) used as a temporary cover when human tissue is not the plan

Every class fails on the same three bedside mistakes. First, the bed is dirty : slough, untreated osteomyelitis, or heavy bioburden under a living construct is an expensive culture medium. Second, the bed is ischemic : a product cannot angiogenize a foot that has no inflow. Third, the etiology is ignored : a plantar product without offloading is walked off by lunchtime; a gaiter product without compression is washed off by edema. Facility formulary and payer rules decide which named product is stocked. Your exam job is the bed, not the catalog number.

Prepare the wound as you would for a graft: debride to healthy tissue, control exudate enough that the construct can contact the bed, and confirm the person can return for the protocol’s dressing sequence. If the construct is dislodged, desiccated, or sitting in pus at the first check, the failure is usually preparation or mechanics, not a mysterious product defect.